Pura Vida Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Pura Vida Investments’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-789,603	Closed	-$3.65M	–	161
2020 Q2	$3.65M	Sell	789,603 -657,350	-45%	-$2.95M	0.35%	67
2020 Q1	$5.57M	Buy	+1,446,953	New	+$5.94M	0.66%	37
2019 Q2	–	Sell	-197,594	Closed	-$1.01M	–	105
2019 Q1	$1.01M	Buy	197,594 +17,396	+10%	+$51.1K	0.14%	92
2018 Q4	$346K	Sell	180,198 -22,291	-11%	-$63.8K	0.07%	65
2018 Q3	$765K	Buy	202,489 +52,489	+35%	+$164K	0.16%	95
2018 Q2	$468K	Buy	+150,000	New	+$455K	0.19%	83
2015 Q4	–	Sell	-100,129	Closed	-$300K	–	78
2015 Q3	$300K	Sell	100,129 -294,871	-75%	-$1.27M	0.17%	61
2015 Q2	$1.95M	Buy	395,000 +30,000	+8%	+$120K	1%	48
2015 Q1	$1.58M	Buy	365,000 +50,000	+16%	+$180K	0.82%	44
2014 Q4	$936K	Buy	+315,000	New	+$864K	0.34%	59

Other funds holding CPRX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Pura Vida Investments's CPRX Position: Q3 2020 in Review

Pura Vida Investments sold out of Catalyst Pharmaceutical (CPRX) in Q3 2020, closing a stake of 789,603 shares — an estimated $3.65M sold.

Pura Vida Investments first reported a position in CPRX in Q4 2014 and held it in 10 quarters. The position peaked at $5.57M in Q1 2020. 142 funds tracked by Wall St. Rank hold CPRX as of Q3 2020.

Pura Vida Investments reported no remaining Catalyst Pharmaceutical position as of Q3 2020 after selling out during the quarter.
Pura Vida Investments sold 789,603 Catalyst Pharmaceutical shares in Q3 2020, an estimated $3.65M.
Pura Vida Investments first reported a position in Catalyst Pharmaceutical in Q4 2014 and held it in 10 quarters.
Pura Vida Investments's Catalyst Pharmaceutical position peaked at $5.57M in Q1 2020.
142 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2020.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.